Kepos Capital LP - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 275 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2018. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
Kepos Capital LP ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q2 2019$935,000
-61.6%
19,363
-59.8%
0.10%
-48.1%
Q1 2019$2,436,000
-14.8%
48,2190.0%0.18%
-17.2%
Q4 2018$2,858,000
-10.0%
48,2190.0%0.22%
+35.6%
Q3 2018$3,174,000
+30.3%
48,2190.0%0.16%
+31.5%
Q2 2018$2,435,000
+356.0%
48,219
+375.8%
0.12%
+300.0%
Q1 2018$534,00010,1340.03%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Zebra Capital Management LLC 25,250$784,0002.30%
Global Alpha Capital Management Ltd. 418,030$12,976,0001.40%
AIMZ Investment Advisors, LLC 70,588$2,191,0001.05%
PALISADE CAPITAL MANAGEMENT, LP 566,080$17,571,0000.48%
RICE HALL JAMES & ASSOCIATES, LLC 261,533$8,118,0000.39%
EARNEST PARTNERS LLC 1,844,621$57,257,0000.38%
SummerHaven Investment Management, LLC 14,476$449,0000.30%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,085,874$33,706,0000.26%
Ridgewood Investments LLC 10,004$311,0000.24%
DUALITY ADVISERS, LP 65,650$2,038,0000.20%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders